At least, that is what doctors thought the first day he was in the hospital in late June.

Detailed price information for Alterity Therapeutics Ltd ADR (ATHE-Q) from The Globe and Mail including charting and trades.

Muscle atrophy is when muscles shrink from lack of use. It can occur due to an injury, a neurological condition, or from a ...

Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension – – New analysis increases overall confidence in the Phase 2 trial results – – State-of-the-art neuroimaging ...

The MS for Dwyfor Meirionnydd hosts an event at the Senedd, urging greater support for rare diseases, especially in the Welsh ...

Could an anomaly in the developing brain explain motor difficulties occurring decades later in people with rare movement ...

Alterity Therapeutics (ASX:ATH) CEO Dr David Stamler presented new analyses from the phase II double-blinded ATH434-201 trial in MSA, showing positive effects on slowing disease progression and ...

Amyotrophic lateral sclerosis may involve an autoimmune component — a finding that could reshape treatment strategies and ...

Alterity Therapeutics (ATHE) announced that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy ...

Researchers analyzed longitudinal changes in substructure brain volumes after menopause in women with multiple sclerosis.

In the three years since a leadership change, Teva has evolved its R&D approach beyond a long history making copycat medicines.